Oncology News and Research RSS Feed - Oncology News and Research Twitter

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.
Scientists discover promising approach to combat life-threatening bacterial infections without antibiotics

Scientists discover promising approach to combat life-threatening bacterial infections without antibiotics

Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. [More]
NorthShore launches first clinical trial to examine GRS test for cancer risk assessment

NorthShore launches first clinical trial to examine GRS test for cancer risk assessment

Researchers at NorthShore University HealthSystem have launched the first clinical trial to investigate a genetic risk score (GRS) test to predict the risk of breast, prostate and colorectal cancer in the primary care setting. [More]
Identifying new pathway of EZH2 gene may lead to targeted therapies for aggressive breast cancer

Identifying new pathway of EZH2 gene may lead to targeted therapies for aggressive breast cancer

Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas. [More]
Research underscores need to improve mental health screening for adolescent cancer survivors

Research underscores need to improve mental health screening for adolescent cancer survivors

Most adolescent survivors of childhood cancer have no reported psychological symptoms, but an analysis led by St. Jude Children's Research Hospital found that those who do often have multiple symptoms and distinct symptom profiles. [More]
Study finds new data about dMMR's hereditary basis in rectal cancer

Study finds new data about dMMR's hereditary basis in rectal cancer

Up to 15 percent of colorectal cancers show a genetic mutation known as DNA mismatch repair deficiency, or dMMR. [More]
New mathematical model can help predict breast cancer growth, occurrence of metastases

New mathematical model can help predict breast cancer growth, occurrence of metastases

Personalized medicine is a healthcare approach in which medical procedures are tailored to the individual patient's genetic, physiological, and biochemical type along with other characteristics. Cancer treatment is one type of care where a personalized approach is most needed and often applied. [More]
New method helps characterize immune cells in tumor tissues

New method helps characterize immune cells in tumor tissues

Despite recent achievements in the development of cancer immunotherapies, only a small group of patients typically respond to them. Predictive markers of disease course and response to immunotherapy are urgently needed. [More]
Adjuvant chemotherapy may improve survival in stage 2 colon cancer patients

Adjuvant chemotherapy may improve survival in stage 2 colon cancer patients

Researchers and physicians have grappled with the role of "adjuvant," or post-surgery, chemotherapy for patients with early-stage colon cancer, even for cancers considered high risk. [More]
TUM scientists discover molecular signaling pathway for self-destruction in leukemia cells

TUM scientists discover molecular signaling pathway for self-destruction in leukemia cells

When adults develop blood cancer, they are frequently diagnosed with what is referred to as acute myeloid leukemia. [More]
E-cigarettes likely to provide public health benefits, study finds

E-cigarettes likely to provide public health benefits, study finds

A modeling study by top tobacco control experts finds that e-cigarettes are likely to provide public health benefits based on "conservative estimates" of the likely uptake of vaping and smoking by adolescents and young adults. [More]
Scientists discover novel genetic mutation linked to osteonecrosis of femoral head

Scientists discover novel genetic mutation linked to osteonecrosis of femoral head

Scientists at the Research Institute of McGill University Health Centre have discovered a new genetic mutation linked to osteonecrosis of the hip, specifically the femoral head - the spherical-shaped mass at the top of the femur. [More]
Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Expanding the potential of existing cancer therapies: an interview with Dr Mark Rutstein

Cancer remains a leading cause of death worldwide, and the global cancer burden is expected to increase by 70 percent over the next two decades. [More]
Study finds low rates of baseline BMD testing among older women with breast cancer

Study finds low rates of baseline BMD testing among older women with breast cancer

Aromatase inhibitors (AIs)—drugs that stop the production of estrogen in women—are standard adjuvant therapy for post-menopausal women with hormone-receptor positive breast cancer. [More]
New treatment approach may benefit relapsed post-transplant blood cancer patients

New treatment approach may benefit relapsed post-transplant blood cancer patients

For many patients with advanced blood cancers, a stem-cell transplant can drive the disease into remission. However, about one-third of these patients experience a relapse and face a very poor prognosis. [More]
UCLA scientists identify mechanisms of tumor resistance to immunotherapy in advanced melanoma

UCLA scientists identify mechanisms of tumor resistance to immunotherapy in advanced melanoma

UCLA researchers have for the first time identified mechanisms that determine how advanced melanoma can become resistant to immune checkpoint inhibitors, a discovery that could lead to the development of new and improved treatments for the deadliest type of skin cancer. [More]
Phase III clinical study of promising prostate cancer drug reveals surprising results

Phase III clinical study of promising prostate cancer drug reveals surprising results

A recently published international clinical Phase III trial of a promising drug for treating advanced prostate cancer ended with surprising results: the new therapeutic agent failed to achieve any significant improvement in the overall survival of patients compared with the established standard treatment. [More]
Research findings unveil new avenues to monitor, treat lung cancer more effectively

Research findings unveil new avenues to monitor, treat lung cancer more effectively

A team of researchers from Singapore has discovered a class of small RNA molecules, known as oncomiRs, which are responsible for fuelling lung cancer. [More]
Immunotherapy cancer trials presented to key opinion leaders

Immunotherapy cancer trials presented to key opinion leaders

Immodulon recently met with some of the world’s most renowned oncologists to present their forthcoming trials for immunotherapy treatment, IMM-101. [More]
International project to develop globally accessible bank of new cancer cell models for research

International project to develop globally accessible bank of new cancer cell models for research

An international project to develop a large, globally accessible bank of new cancer cell culture models for the research community launched today. [More]
Study shows feasibility to adopt salpingectomy in large scale clinical practice without surgical repercussions

Study shows feasibility to adopt salpingectomy in large scale clinical practice without surgical repercussions

A surgical procedure recommended to reduce the future risk of ovarian cancer has been successfully implemented throughout Kaiser Permanente in Northern California without a change in surgical outcomes, according to research published today in the journal Obstetrics & Gynecology. [More]
Advertisement